AACR will feature 13 sessions addressing key issues in regulatory science and science policy.
(Adobe Acrobat Reader Required)
From funding research grants to minimizing the barriers to clinical trials, the decisions made in Washington, D.C., directly influence the rate of progress in the war against cancer. Issues regarding health and science are becoming increasingly complex, and competition for limited resources is steadily increasing. These times require that cancer researchers become more actively involved in the policy-making process and take time to educate the public about the exciting progress occurring in the fight against cancer.
The AACR's principal means for devising and implementing strategies to influence funding and important biomedical research-related public policy issues through The Science Policy and Government Affairs Committee and its subcommittees:
Science Policy and Government Affairs Committee - Provides guidance on public issues of concern to cancer researchers and focuses on mechanisms for speeding up cancer research.
AACR CONGRESSIONAL BRIEFING
MAKING RESEARCH COUNT FOR PATIENTS:
A CONTINUAL PURSUIT
Thursday, March 13, 2014
The AACR will showcase the AACR Cancer Progress Report 2013 at a congressional briefing titled “Making Research Count for Patients: A Continual Pursuit.” The congressional briefing will be held on March 13, from 12:00 p.m. -1:30 p.m. in Room B339 of the Rayburn House Office Building and will highlight the remarkable progress investments in cancer research and biomedical science have made for cancer patients and survivors in 2013. AACR CEO Margaret Foti, Ph.D., M.D. (h.c.) and AACR President Charles L. Sawyers, M.D., will lead a panel of experts, which also will include a cancer survivor featured in the report, Hans Loland.
To RSVP for the AACR Cancer Progress Report 2013 congressional briefing, please complete the online form.
CANCER POLICY RESOURCES
AACR OFFICE OF SCIENCE POLICY & GOVERNMENT AFFAIRS
1425 K Street, NW, Suite 250
Washington, D.C. 20005
(202) 898-6499 (Phone)
(202) 898-0966 (Fax)